In-vitro anti-proliferative effects of some anti-tumour drugs on feline mammary tumour cell lines

Research in Veterinary Science

Volumn 66, Issue 3, 1999, Pages 169-174

  Muleya, J S ^a   Nakaichi, M ^a   Taura, Y ^a   Yamaguchi, R ^b   Nakama, S ^a  

^a YAMAGUCHI UNIVERSITY   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; MITOXANTRONE; RECOMBINANT GAMMA INTERFERON; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; VINCRISTINE;

ANIMAL CELL; ARTICLE; BREAST ADENOCARCINOMA; BREAST CELL; CAT; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; MONOLAYER CULTURE; NONHUMAN; TUMOR CELL LINE;

EID: 0033053891     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1053/rvsc.1998.0218     Document Type: Article

References (22)

1. BONNADONNA, G. & VALLAGUSSA, P. (1988) Adjuvant chemotherapy for breast cancer. Seminars in Surgical Oncology 4, 250-255
2. CARMICHAEL, J., MITCHEL, J. B., DEGRAFF, W. G., GAMDAR, A. F., JOHNSON, B. E., GLASTEIN, E. & MINNA, J. D. (1985) Chemosensitivity testing of human lung cancer cells using the MTT assay. British Journal of Cancer 57, 540-547
3. DOLLBAUM, C., CREASEY, A. A., DAIRKEE, S. H., HILLER, A. J., RUDOLF, A., LIN, L. VITT, C. & SMITH, H. S. (1988) Specificity of TNF toxicity for human mammary carcinomas relative to normal mammary epithelium and coR.R.ellation with response to doxorubicin. Proceedings of the National Academy of Sciences in the United States of America 85, 4740-4744
4. FERGUSON, P. J., ROBERTS PHILLIP, J., SELNER, M. & CASS, C. E. (1984) Differential activity of vincristine and vinblastine against cultured cells. Cancer Research 44, 3307-3312
5. GIAI, M., BIGLIA, N. & SISMONDI, P. (1991) Chemoresistance in breast tumors. European Journal of Gynaecological Oncology 12, 375-373
6. HAHN, K. A., McENTEE, M. F., DANIEL, G. B., LEGENDRE, A. M. & NOLAN, M. L. (1997) Haematological and systemic toxicosis associated with carboplatin administered in cats. American Journal of Veterinary Research 58, 677-679
7. HIRVIKOSKI, P. P., KUMPULAINEN, E. J. & JOHANSSON, R. T. (1997) CNF combination as adjuvant treatment in breast cancer is well tolerated. Anti-Cancer Research 8, 376-378
8. ISHIKAYA, M., SHIGA, M., SASAMOTO, K., MIZOGUCHI, M. & HE, P. (1993) A new sulfonated tetrazolium salt that produced highly water soluble formazan dye. Chemical & Pharmaceutical Bulletin 41, 1118-1122
9. JEGLUM, A. K., deGUZMAN, E. & YOUNG, K. M. (1985) Chemotherapy of advanced mammary adenocarcinoma. Journal of the American Veterinary Medical Association 187, 157-160
10. KNAPP, D. W., RICHARDSON, R. C., DeNICOLA, D. B., LONG, G. G. & BLEVIN, W. E. (1987) Cisplatin toxicity in cats. Journal of Veterinary Internal Medicine 1, 29-35
11. MAULDIN, G. N., MALUS, R. E. & PATNAIK, A. K. (1988) Efficacy and toxicity of doxorubicin and cyclophosphamide in the treatment of selected malignant tumors in 23 cats. Journal of Veterinary Internal Medicine 2, 60-65
12. MULEYA, J. S., NAKAICHI, M., SUGAHARA, J., TAURA, Y., MURATA, T. & NAKAMA, S. (1998) Establishment and characterization of a new cell line derived from feline mammary tumor. The Journal of Veterinary Medical Science 60, 931-935
13. MOSMANN, T. (1983) Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. Journal of Immunological Methods 65, 55-63
14. NAKAJIMA, Y., DELLIPEZZI, A., MALLOUH, C. & FERRERI, N. R. (1995) Effects of tumor necrosis factor alfa and interferon gamma on the growth of human prostate cancer cells. Urological Research 23, 205-210
15. OGILVIE, G. K., MOORE, A. S., OBRADOVICH, J. E., ELMSLIE, R. E., VAIL, D. M., STRAW, R. C., SALMON, M. D., KLEIN, M. K., ATWATER, S. W. & CIEKOT, P. E. (1993) Toxicoses and efficacy associated with administration of mitoxantrone to cats with malignant tumors. Journal of the American Veterinary Medical Association 202, 1839-1844
16. PROP, F. J. A., WEIJER, K., SPIES, J., SOUW, L., PETERS, K., ERICH, T., RIJNHART, P. & MISDORP, W. (1986) Feline mammary carcinoma as a model for human breast cancer. I. Sensitivity of mammary tumour cells in culture to cytotoxic drugs. Anti-cancer Research 6, 989-994
17. REPETTO, L., SIMONI, C., VENTURINO, A., BIANCARDI, V., GASCO, M., CAMPORA, E. & ROSSO, R. (1995) Mitoxantrone in elderly women with advanced breast cancer: a phase II study. Anti-cancer Research 15, 2297-2300
18. SMITH, S. H., ZOLI, W., VOLPI, A., HILLER, A., LIPPMAN, M., SWAIN, S., MAYALL, B., DOLLBAUM, C., HACKETT, J. A. & AMADORI, D. (1990) Preliminary correlations of clinical outcome with in vitro chemosensitivity of second passage human breast cancer cells. Cancer Research 50, 2943-2948
19. STOLWIJK, J. A. M., MINKE, J. M. H. M., RUTTERMAN, G. R., HEOKSTRA, J., PROP, F. J. A. & MISDORP, W. (1989) Feline mammary carcinoma as a model for human breast cancer. II. Comparison of in vivo in in vitro adriamycin sensitivity. Anti-cancer Research 9, 1045-1048
20. TATEYAMA, S., PRIOSOERYANTO, B. P., YAMAGUCHI, R. & UCHIDA, K. (1995) In vitro growth inhibition activities of recombinant feline interferon on all cell lines derived from canine tumours. Research in Veterinary Science 59, 275-277
21. WEIJER, K. & HART, A. A. M. (1983) Prognostic factors in feline mammary carcinoma. Journal of the National Cancer Institute 70, 709-716
22. WEIJER, K., HEAD, K. W., MISDORP, W. & HAMPE, J. F. (1972) Feline malignant tumours. I. Morphology and biology: some comparisons with human mammary carcinoma. Journal of the National Cancer Institute 49, 1697-1704